Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Pioglitazone + Metformin
Competact
Not routinely available
SMC (252/06)
29/03/2023
Indication
Type 2 diabetes mellitus. See link to SMC advice for full details of restriction.
Therapeutic Area
Endocrine system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
15mg/850mg tablets
Comments
-
Link to Advice
Advice Published
11/09/2006
SMC Submission Type
Abbreviated
SMC Status
Restricted